Here are relevant reports on : health-it-market

• Food as Medicine Market By Product Type (Functional Foods, Medical Foods, Nutraceuticals, Personalized Nutrition Products, Therapeutic Food Products), Function (Metabolic Health, Diabetes Management, Cardiovascular Health, Gastrointestinal Health, Immune Health, Other Functions), Ingredient Type, Source, Form, Distribution Channel, Prescription Type (Qualitative), and Region – Global Forecast to 2031

  The food as medicine market is estimated at USD 254.15 billion in 2026 and is projected to reach USD 400.81 billion by 2031, at a CAGR of 9.5% from 2026 to 2031 The Key Players Nestlé Health Science (Switzerland), Danone (France), Abbott Nutrition (US), Reckitt Mead Johnson (UK), FrieslandCampina (Netherlands), Herbalife (US), Amway (US), Novonesis (Denmark), Yakult Honsha Co., Ltd. (Japan), Unilever (UK), Otsuka Holdings (Japan), Probi AB (Sweden), Church & Dwight Co., Inc. (US), Meiji Holdings (Japan), and Jamieson Wellness (Canada).

  • Published: September 2026
  • Price: $ 4950
  • TOC Available:

• Vitamin K2 Market by Application (Health Supplements, Functional Food & Beverages, Pharmaceutical), Product Type (MK-7, MK-4), Application Form (Capsules & Tablets, Powder & Crystalline, Liquids), Source, Function, and Region - Global Forecast to 2031

  The Vitamin K2 market is estimated to be USD 179.0 million in 2026 and is projected to reach USD 339.9 million by 2031, at a CAGR of 13.7% from 2026 to 2031. The report profiles key players such as Gnosis by Lesaffre (France), Balchem Corp (US), J-OIL MILLS, INC (Japan), Novonesis A/S (Denmark), Guangdong Sungen Bioscience Co., Ltd. (China), Vesta Nutra (US), Menadiona (Spain), GF Fermentech (South Korea), AngelYeast Co., Ltd. (China), and GeneFerm Biotechnology Co., Ltd. (Taiwan).

  • Published: July 2026
  • Price: $ 4950
  • TOC Available:

• Wearables in Pharma & Biotech Market by Product (Smartwatches, CGMs, Bands, Rings, Patches, Injectors), Therapy (Diabetes, Cardio, Onco, Mental Health), Application (Drug Discovery, Clinical Trials, Medication Adherence), End User - Global Forecasts to 2031

  The global wearables in pharma & biotech market is projected to reach USD 9.97 billion by 2031, growing at a CAGR of 20.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.

  • Published: April 2026
  • Price: $ 4950
  • TOC Available:

• IoT Connectivity Market by Component (Platform, Services), Organization Size, Application Areas (Building &Home Automation, Smart Energy & Utility, Smart Manufacturing, Connected Health, Smart Retail, Smart Transportation), Region - Global Forecast to 2024

  IoT Connectivity market is expected to grow USD 8.9 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 18.7% during the forecast period. Key and emerging market players include AT&T (US), Cisco (US), Verizon (US), Vodafone (UK), Ericsson (Sweden), Sierra Wireless (Canada), Orange (France), Telefónica (Spain), Huawei (China), Telit (Italy), Hologram (US), Particle (US), Aeris (US), Sigfox (France), EMnify (Germany), and Moeco (US). These players have adopted various strategies to grow in the IoT connectivity market.

  • Published: July 2019
  • Price: $ 4950
  • TOC Available:

• Asia Pacific Animal Health Market by product (Parasiticides (Ectoparasiticides), Antimicrobial & Antibiotic, Vaccines, Feed Additive( Vitamin, Amino Acids, Antioxidant), Growth Promoter) Animal (Livestock, Companion), End-user (Hospitals) & Region - Global Forecast to 2025

  The global Asia Pacific Animal Health Market in terms of revenue was estimated to be worth $15.6 billion in 2020 and is poised to reach $22.1 billion by 2025, growing at a CAGR of 7.2% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

  • Published: November 2020
  • Price: $ 4950
  • TOC Available:

• Prostate Health Market by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx), & Region (NA, Europe, APAC) - Global Forecast to 2026

  The global prostate health market growth is primed to transition from USD 31.8 billion in 2021 to USD 48.9 billion by 2026, showcasing a strong CAGR of 9.0%. Growth in this market is primarily driven by the increasing prevalence of benign prostatic hyperplasia, increasing obesity, investments, funds, and grants for research in prostate health, an increase in the prevalence of prostate cancer, a surge in demand for hormone therapy drugs, emerging therapies for prostate cancer, and an increasing incidence of prostatitis.

  • Published: December 2021
  • Price: $ 4950
  • TOC Available:

• Precision Biotics Market by Type (Precision Probiotics, Next-generation Probiotics, Synbiotics, Postbiotics), End-use Industry, Health/Functional Positioning, Distribution Channel, and Region - Global Forecast to 2031

  The precision biotics market is estimated at USD 4.91 billion in 2026 and is projected to reach USD 9.26 billion by 2031, at a CAGR of 13.5% from 2026 to 2031. The report profiles key players such as BioGaia (Sweden), Novonesis Group (Denmark), Procter & Gamble (US), Unilever (UK), dsm-firmenich (Switzerland), Metagenics, LLC (US), Yakult Honsha Co., Ltd (Japan), Danone (France), KANEKA CORPORATION (Japan), Symrise (Germany)-(Probi), Jarrow Formulas, Inc (US), Pendulum (US), thegoodbug (India), Seed Health, Inc (US), and Infinant Health Inc (US).

  • Published: July 2026
  • Price: $ 4950
  • TOC Available:

• Specialty PACS Market by Type (Radiology, Orthopedics, Oncology, Pathology, Endoscopy, Women's Health), Deployment Model (On premise, Cloud), Component (Software, Service), End User (Hospital, Clinic, Diagnostic Centers, Research) - Global Forecasts to 2024

  The global specialty PACS market size is projected to reach USD 3.5 billion in 2024, at a CAGR of 6.0%. Some of the prominent players offering in this market includes IBM Corporation (Merge Healthcare Incorporated) (US), McKesson Corporation (US), Agfa Healthcare (Belgium), Carestream Health (a part of Onex Corporation) (Canada), Philips Healthcare (Netherlands), Sectra AB (Sweden), Siemens Healthineers (Germany), Novarad (US), INFINITT North America (US), Intelerad Medical Systems (Canada), Topcon Corporation (Japan), Sonomed Escalon (US), Canon USA, Inc. (US) (a subsidiary of Canon Inc.), Visbion (UK), and EyePACS, LLC (US).

  • Published: September 2019
  • Price: $ 4950
  • TOC Available:

• Environment, Health, and Safety Market by Offering (Software and Services (Analytics, Project Deployment and Implementation, Audit, Assessment, and Regulatory Compliance, Certification)), Application, Vertical & Region - Global Forecast to 2029

  The environment, health, and safety market size is projected to reach USD 11.5 billion by 2029 at a CAGR of 7.6% during the forecast period. The report profiles key players such as VelocityEHS (US), Wolters Kluwer (Netherlands), Intelex Technologies (Canada), Benchmark ESG (US), Cority Software Inc. (Canada), Sphera (US), Intertek (UK), Quentic (Germany), UL Solutions (US), Ideagen (UK), SAP (Germany), IBM (US), Evotix (UK), EcoOnline (Norway), Diligent Corporation (US), ETQ (US), 3E (US), Dakota Software Corporation (US), IsoMetrix (US), Enhesa (US), VisiumKMS (US), SafetyCulture (Australia), TextContext (Canada), ComplianceQuest (US), Pro-Sapien (UK), SHEQX (Australia), CMO Software (UK), Indus Environmental Services (India), Inicia (Japan), ASK-EHS Engineering (India), SHE Group (South Africa), and EHS Brazil (Brazil).

  • Published: April 2024
  • Price: $ 4950
  • TOC Available:

• Brain Computer Interface Market by Product (Non-invasive, Invasive, Partial invasive), Technology (EEG, MEG, ECoG, fMRI), Application (Disability/Rehabilitation, Assistive technologies, Mental health, Research), End User - Global Forecast to 2029

  The global brain computer interface market, valued at US$235 million in 2023, stood at US$262 million in 2024 and is projected to advance at a resilient CAGR of 14.1% from 2024 to 2029, culminating in a forecasted valuation of US$506 million by the end of the period. The growth of this market is driven by the growing incidence & prevalence of neurological disorders, increasing demand for non-invasive and wearable brain computer interface devices, and rising Investments in research and development.

  • Published: May 2024
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS
• NEXT
• LAST

Records 31 to 40 of 50